Affimed NV has a consensus price target of $9.44 based on the ratings of 10 analysts. The high is $25 issued by Laidlaw & Co. on June 13, 2024. The low is $4 issued by Stifel on November 15, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, HC Wainwright & Co., and Stifel on December 12, 2024, December 10, 2024, and November 15, 2024, respectively. With an average price target of $9.67 between Wells Fargo, HC Wainwright & Co., and Stifel, there's an implied 1434.39% upside for Affimed NV from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
12/12/2024 | Buy Now | 2280.95% | Wells Fargo | Yanan Zhu35% | $20 → $15 | Maintains | Overweight | Get Alert |
12/10/2024 | Buy Now | 1487.3% | HC Wainwright & Co. | Swayampakula Ramakanth47% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
11/19/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek38% | — | Reiterates | → Overweight | Get Alert |
11/15/2024 | Buy Now | 534.92% | Stifel | Bradley Canino38% | $5 → $4 | Maintains | Hold | Get Alert |
11/15/2024 | Buy Now | 1487.3% | HC Wainwright & Co. | Swayampakula Ramakanth47% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
09/09/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek38% | — | Reiterates | → Overweight | Get Alert |
09/06/2024 | Buy Now | 1487.3% | HC Wainwright & Co. | Swayampakula Ramakanth47% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
06/13/2024 | Buy Now | 3868.25% | Laidlaw & Co. | Yale Jen20% | $15 → $25 | Maintains | Buy | Get Alert |
06/13/2024 | Buy Now | 1487.3% | HC Wainwright & Co. | Swayampakula Ramakanth47% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
06/03/2024 | Buy Now | 1487.3% | HC Wainwright & Co. | Swayampakula Ramakanth47% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
04/01/2024 | Buy Now | 3868.25% | Wells Fargo | Yanan Zhu35% | $30 → $25 | Maintains | Overweight | Get Alert |
04/01/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek38% | — | Reiterates | → Overweight | Get Alert |
04/01/2024 | Buy Now | 693.65% | Stifel | Bradley Canino38% | $1 → $5 | Maintains | Hold | Get Alert |
04/01/2024 | Buy Now | 1487.3% | HC Wainwright & Co. | Swayampakula Ramakanth47% | $5 → $10 | Maintains | Buy | Get Alert |
11/15/2023 | Buy Now | 693.65% | HC Wainwright & Co. | Swayampakula Ramakanth47% | → $50 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | Buy Now | 376.19% | Wells Fargo | Yanan Zhu35% | $4 → $3 | Maintains | Overweight | Get Alert |
09/25/2023 | Buy Now | 1011.11% | Cantor Fitzgerald | Li Watsek38% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
09/12/2023 | Buy Now | 1011.11% | Cantor Fitzgerald | Li Watsek38% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
09/07/2023 | Buy Now | 1011.11% | Cantor Fitzgerald | Li Watsek38% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
08/11/2023 | Buy Now | 534.92% | Wells Fargo | Yanan Zhu35% | $5 → $4 | Maintains | Overweight | Get Alert |
08/11/2023 | Buy Now | 852.38% | Truist Securities | Srikripa Devarakonda38% | $80 → $60 | Maintains | Buy | Get Alert |
08/11/2023 | Buy Now | 693.65% | HC Wainwright & Co. | Swayampakula Ramakanth47% | → $50 | Reiterates | Buy → Buy | Get Alert |
08/08/2023 | Buy Now | 852.38% | Berenberg | Andy Chen32% | → $60 | Assumes | → Buy | Get Alert |
06/05/2023 | Buy Now | 693.65% | HC Wainwright & Co. | Swayampakula Ramakanth47% | $60 → $50 | Maintains | Buy | Get Alert |
05/25/2023 | Buy Now | 693.65% | Wells Fargo | Yanan Zhu35% | $7 → $5 | Maintains | Overweight | Get Alert |
05/24/2023 | Buy Now | 852.38% | HC Wainwright & Co. | Swayampakula Ramakanth47% | → $60 | Reiterates | Buy → Buy | Get Alert |
03/27/2023 | Buy Now | 1011.11% | Wells Fargo | Yanan Zhu35% | → $70 | Assumes | → Overweight | Get Alert |
03/24/2023 | Buy Now | 58.73% | Stifel | Bradley Canino38% | $20 → $10 | Maintains | Hold | Get Alert |
03/24/2023 | Buy Now | 852.38% | HC Wainwright & Co. | Swayampakula Ramakanth47% | → $60 | Reiterates | → Buy | Get Alert |
12/12/2022 | Buy Now | 1011.11% | Wells Fargo | James Shin32% | $80 → $70 | Maintains | Overweight | Get Alert |
12/12/2022 | Buy Now | 852.38% | Piper Sandler | Do Kim55% | $70 → $60 | Maintains | Overweight | Get Alert |
12/12/2022 | Buy Now | 852.38% | SVB Leerink | Daina Graybosch43% | $100 → $60 | Maintains | Outperform | Get Alert |
12/12/2022 | Buy Now | 852.38% | HC Wainwright & Co. | Swayampakula Ramakanth47% | → $60 | Initiates | → Buy | Get Alert |
10/10/2022 | Buy Now | 217.46% | Stifel | Bradley Canino38% | $90 → $20 | Downgrade | Buy → Hold | Get Alert |
06/23/2022 | Buy Now | 1328.57% | SVB Leerink | Daina Graybosch43% | $100 → $90 | Maintains | Outperform | Get Alert |
The latest price target for Affimed (NASDAQ:AFMD) was reported by Wells Fargo on December 12, 2024. The analyst firm set a price target for $15.00 expecting AFMD to rise to within 12 months (a possible 2280.95% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Affimed (NASDAQ:AFMD) was provided by Wells Fargo, and Affimed maintained their overweight rating.
There is no last upgrade for Affimed
The last downgrade for Affimed NV happened on October 10, 2022 when Stifel changed their price target from $9 to $2 for Affimed NV.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on December 12, 2024 so you should expect the next rating to be made available sometime around December 12, 2025.
While ratings are subjective and will change, the latest Affimed (AFMD) rating was a maintained with a price target of $20.00 to $15.00. The current price Affimed (AFMD) is trading at is $0.63, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.